Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 06, 2024 06:30 ET | Source: BitFuFu Inc.

BitFuFu to Attend Upcoming Investor Conferences in September

Singapore, Sept. 06, 2024 (GLOBE NEWSWIRE) -- BitFuFu, Inc. (NASDAQ: FUFU, FUFU.WS) (“BitFuFu” or the “Company”) a fast-growing digital asset mining service and world-leading...
September 03, 2024 16:01 ET | Source: Genelux Corporation

Genelux Corporation to Present at the H.C. Wainwright Global Investment Conference

WESTLAKE VILLAGE, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick, President,...
November 09, 2022 16:05 ET | Source: Revolution Medicines, Inc.

Revolution Medicines to Participate in Upcoming Investor Conferences

REDWOOD CITY, Calif., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, today...
September 06, 2022 06:00 ET | Source: AppTech Corp.

AppTech Payments Corp. to Present at the H.C. Wainwright 24th Annual Global Investment Conference

CARLSBAD, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- AppTech Payments Corp. (AppTech) (NASDAQ: APCX), an innovative Fintech company powering commerce experiences, today announced its Chairman and...
May 23, 2022 06:30 ET | Source: Nemaura Medical, Inc

Nemaura Medical Strengthens Balance Sheet with Further Non-Dilutive Funding

Loughborough, England, May 23, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD), a medical technology company focused on commercializing a daily disposable wearable glucose sensor and...
September 14, 2020 08:30 ET | Source: Monopar Therapeutics Inc.

Monopar Therapeutics to Present at the H.C. Wainwright 22nd Annual Global Investment Conference on September 16, 2020

WILMETTE, Ill., Sept. 14, 2020 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR) today announced that Chandler D. Robinson, MD, Chief Executive Officer, will present a corporate update at...
September 11, 2020 15:00 ET | Source: Surface Oncology, Inc.

Surface Oncology to Participate in the H.C. Wainwright Global Healthcare Conference

CAMBRIDGE, Mass., Sept. 11, 2020 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor...
September 09, 2020 07:30 ET | Source: Revolution Medicines, Inc.

Revolution Medicines to Present at the H.C. Wainwright 22nd Annual Global Investment Conference

REDWOOD CITY, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage precision oncology company focused on developing targeted therapies to inhibit...
August 24, 2020 08:00 ET | Source: Cancer Genetics, Inc.

Cancer Genetics and StemoniX Sign Definitive Agreement to Merge

Combined Company Positioned to Offer Best-in-Class and Innovative Drug Discovery Solutions RUTHERFORD, NJ and MAPLE GROVE, MN, Aug. 24, 2020 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (the...